Pritesh R. Patel
Expertise in
4
conditions

Dr. Pritesh R. Patel

Radiology
Froedtert Menomonee Falls Hospital
W180 N8085 Town Hall Rd., 
Menomonee Falls, WI 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
18 Years of Experience
Referral may be required
Before you request
Expertise in
4
conditions
Froedtert Menomonee Falls Hospital
W180 N8085 Town Hall Rd., 
Menomonee Falls, WI 

Overview

Pritesh Patel is a Radiologist practicing medicine in Menomonee Falls, Wisconsin. He has been practicing medicine for over 18 years.

Dr. Patel is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Gas Bloat Syndrome, Ascites, Visceromegaly, Tissue Biopsy, and Prostatectomy.

Dr. Patel is board certified in Diagnostic Radiology. He is actively involved in clinical research, co-authoring 83 peer reviewed articles and participating in 8 clinical trials. Dr. Patel is currently accepting new patients.

Graduate Year

2008

Specialties

Radiology

Licenses

Diagnostic Radiology in IL

Board Certifications

Diagnostic Radiology

Fellowships

Harvard Medical School – Massachusetts General Hospital - Boston - MA - Fellowship in Abdominal Imaging and Intervention - (2013-2014)

Hospital Affiliations

Froedtert Memorial Lutheran Hospital
Community Memorial Hospital
Froedtert Community Hospital
St Josephs Community Hospital West Bend

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

Froedtert Menomonee Falls Hospital
W180 N8085 Town Hall Rd., Menomonee Falls, WI 53051
Other Locations
Froedtert West Bend Hospital
3200 Pleasant Valley Rd., West Bend, WI 53095

Additional Areas of Focus

Dr. Patel has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
Enrollment Status: Recruiting
Publish Date: August 19, 2026
Intervention Type: Other, Biological, Drug
Study Drugs: Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone, Lenalidomide
Study Phase: Phase 3
BMT-06: Phase II Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Cyclophosphamide and Post-Transplant Cyclophosphamide Conditioning for Partially HLA Mismatched Allogeneic Transplantation in Patients With Acute Leukemia and Myelodysplastic Syndrome (MDS)
BMT-06: Phase II Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Cyclophosphamide and Post-Transplant Cyclophosphamide Conditioning for Partially HLA Mismatched Allogeneic Transplantation in Patients With Acute Leukemia and Myelodysplastic Syndrome (MDS)
Enrollment Status: Recruiting
Publish Date: April 06, 2026
Intervention Type: Drug, Other, Radiation, Device
Study Drugs: Fludarabine, Cyclophosphamide, Tacrolimus
Study Phase: Phase 2
A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2026
Intervention Type: Drug, Other, Procedure
Study Drugs: Carmustine, Cyclophosphamide, Cytarabine, Etoposide, Ibrutinib, Melphalan
Study Phase: Phase 3
A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors
A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors
Enrollment Status: Active_not_recruiting
Publish Date: June 16, 2026
Intervention Type: Drug, Procedure
Study Drugs: Paclitaxel, Ifosfamide, Cisplatin, Pegylated G-CSF, G-CSF, Carboplatin, Etoposide Phosphate
Study Phase: Phase 3
S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients With Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study)
S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients With Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study)
Enrollment Status: Active_not_recruiting
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Lenalidomide, Daratumumab/rHuPH20
Study Phase: Phase 3
BMT-03: A Phase I Trial of Total Marrow Irradiation in Addition to High Dose Melphalan Conditioning Prior to Autologous Transplant for Patients With Relapsed or Refractory Multiple Myeloma
BMT-03: A Phase I Trial of Total Marrow Irradiation in Addition to High Dose Melphalan Conditioning Prior to Autologous Transplant for Patients With Relapsed or Refractory Multiple Myeloma
Enrollment Status: Completed
Publish Date: November 13, 2024
Intervention Type: Drug, Procedure, Radiation
Study Drugs: Melphalan, Filgrastim (G-CSF)
Study Phase: Phase 1
A Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib vs. Pomalidomide and Dexamethasone for Patients With Multiple Myeloma Relapsing on Lenalidomide as Part of First Line Therapy
A Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib vs. Pomalidomide and Dexamethasone for Patients With Multiple Myeloma Relapsing on Lenalidomide as Part of First Line Therapy
Enrollment Status: Unknown
Publish Date: December 01, 2023
Intervention Type: Drug
Study Drugs: Pomalidomide, Ixazomib, Dexamethasone
Study Phase: Phase 1/Phase 2
Autologous Stem Cell Therapy for Premature Ovarian Insufficiency and Low Ovarian Reserve
Autologous Stem Cell Therapy for Premature Ovarian Insufficiency and Low Ovarian Reserve
Enrollment Status: Completed
Publish Date: September 23, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
View 6 Less Clinical Trials

83 Total Publications

Accuracy of Real-Time PK-Guided Melphalan Dosing in Achieving Target Exposure in Myeloma Patients Undergoing Autologous Transplant.
Accuracy of Real-Time PK-Guided Melphalan Dosing in Achieving Target Exposure in Myeloma Patients Undergoing Autologous Transplant.
Journal: Pharmaceutics
Published: May 21, 2026
Similar Doctors
Expertise in
5
conditions
Dr. Mohit Maheshwari
Radiology | Pediatric Radiology | Pediatrics
Expertise in
5
conditions
Dr. Mohit Maheshwari
Radiology | Pediatric Radiology | Pediatrics
Referral may be required
Before you request

Radiology Department - Froedtert Hospital

8750 William Coffey Dr., 
Milwaukee, WI 
 (9.3 miles away)
414-805-3700
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Mohit Maheshwari is a Radiologist and a Pediatric Radiologist practicing medicine in Milwaukee, Wisconsin. Dr. Maheshwari is highly rated in 5 conditions, according to our data. His clinical expertise encompasses PHACE Syndrome, Aplasia Cutis Congenita, Clouston Syndrome, and Ectodermal Dysplasias. Dr. Maheshwari is board certified in Diagnostic Radiology. Dr. Maheshwari is currently accepting new patients.

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required
Before you request

Radiology Department - Froedtert Hospital

8750 William Coffey Dr., 
Milwaukee, WI 
 (9.3 miles away)
414-805-3700
Languages Spoken:
English
Accepting New Patients

Keith Baynes is a Radiologist practicing medicine in Milwaukee, Wisconsin. Dr. Baynes is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Melorheostosis, Melorheostosis with Osteopoikilosis, Osteopenia, and Calcium Pyrophosphate Arthritis. Dr. Baynes is board certified in Diagnostic Radiology. Dr. Baynes is currently accepting new patients.

Expertise in
8
conditions
Expertise in
8
conditions
Referral may be required
Before you request

Radiology Department - Froedtert Hospital

8750 William Coffey Dr., 
Milwaukee, WI 
 (9.3 miles away)
414-805-3700
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Joseph Budovec is a Radiologist practicing medicine in Milwaukee, Wisconsin. Dr. Budovec is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Visceromegaly, Ascites, Progressive Familial Intrahepatic Cholestasis Type 3, and Progressive Familial Intrahepatic Cholestasis Type 2. Dr. Budovec is board certified in Diagnostic Radiology. Dr. Budovec is currently accepting new patients.

Frequently Asked Questions about Dr. Pritesh R. Patel

How do I make an appointment with Dr. Pritesh R. Patel?

You can book an appointment with Dr. Pritesh R. Patel by calling their office at 262-251-1000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Pritesh R. Patel a top-rated expert for Gas Bloat Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Pritesh R. Patel is classified as an Advanced expert for Gas Bloat Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Pritesh R. Patel specialize in?

While Dr. Pritesh R. Patel is a Radiology, they have specific expertise in Gas Bloat Syndrome, Ascites, and Visceromegaly. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiology.

Does Dr. Pritesh R. Patel participate in research or clinical trials?

Yes. Dr. Pritesh R. Patel has published 83 articles and abstracts on conditions like Gas Bloat Syndrome. You can view a list of Dr. Pritesh R. Patel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Pritesh R. Patel accept my insurance?

Dr. Pritesh R. Patel accepts most major insurance plans, including Meridian Choice. We recommend calling the office directly at 262-251-1000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Patel's expertise for a condition
ConditionClose
      View All 28 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile